WIN-10 INTEX PHARMA — Research Summary
WIN-10 INTEX PHARMA is a sildenafil citrate compound manufactured by Intex Pharma for in-vitro research applications. Sildenafil citrate is a selective phosphodiesterase type 5 (PDE5) inhibitor originally developed for studying vascular smooth muscle relaxation and nitric oxide signalling pathways. Research teams at Stroid UK Shop investigate this compound’s mechanisms of action in cardiovascular research models. The pharmaceutical grade formulation provides researchers with consistent material for examining PDE5 enzyme inhibition and cGMP pathway modulation in laboratory settings. Scientists study how sildenafil citrate affects endothelial function and vascular reactivity through its selective inhibition of the PDE5 enzyme, which breaks down cyclic guanosine monophosphate (cGMP). This mechanism makes it valuable for investigating pulmonary arterial hypertension models and endothelial dysfunction research protocols.
Laboratory Applications
Research applications for WIN-10 include cardiovascular pharmacology studies, particularly those examining nitric oxide-cGMP signalling cascades and smooth muscle cell biology. Laboratory teams analyse this compound’s effects on phosphodiesterase enzyme activity using biochemical assays and tissue culture systems. Researchers working with sildenafil citrate compounds investigate its role in endothelial nitric oxide synthase (eNOS) pathway research and vascular tone regulation studies. The compound serves as a reference standard in PDE5 inhibitor research and comparative pharmacology experiments. Scientists study its selectivity profile against other phosphodiesterase isoforms and evaluate its potential applications in pulmonary vascular research. Additional research areas include investigating the compound’s effects on platelet aggregation inhibition and its role in studying erectile dysfunction mechanisms at the molecular level. Teams also examine how sildenafil citrate influences retinal blood flow and optic nerve head perfusion in experimental models, contributing to our understanding of ocular pharmacology.
Product Specifications
| Chemical Name | Sildenafil Citrate |
|---|---|
| CAS Number | 171599-83-0 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.70 g/mol |
| Manufacturer | Intex Pharma |
| Product Code | EU2845 |
| Storage | Room temperature, dry conditions |
| Research Grade | Laboratory standard |
The compound’s solubility characteristics and stability profile make it suitable for various research methodologies, including cell culture studies and biochemical assays. Researchers conducting studies alongside SARM compounds often include PDE5 inhibitors as controls or comparative agents in vascular research protocols. Teams working with peptide research may investigate interactions between sildenafil citrate and vasoactive peptides in experimental models.
Research Compliance
WIN-10 INTEX PHARMA is manufactured exclusively for laboratory research purposes and in-vitro scientific investigation. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols, safety measures, and institutional approval before conducting studies with this compound. All research activities should comply with relevant scientific ethics guidelines and institutional review board requirements for chemical research compounds.
